ArticleACS omega2026
Use of Multifunctional Nanoclay@VS
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The scarcity of clean water resources has become a critical global environmental issue due to rapid population growth and unplanned industrialization, which have significantly disrupted natural purification processes. Moreover, the increasing coexistence of persistent organic dyes and pharmaceutical pollutants in wastewater, which are resistant to conventional treatment methods, poses a serious threat to aquatic ecosystems and human health. This situation highlights the urgent need for the development of efficient, sustainable, and multifunctional treatment strategies capable of addressing diverse classes of contaminants simultaneously. The main objective of this study is to develop a multifunctional nanocomposite material capable of integrating adsorption and photocatalytic processes for the effective removal of both dye and pharmaceutical pollutants. In this context, the removal of methylene blue (MB), a widely encountered industrial dye, and escitalopram (ESC), a pharmaceutical contaminant, was investigated using multifunctional Nanoclay@VS
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.